Statements (36)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
hydroxyzine pamoate
|
| gptkbp:approvedBy |
gptkb:United_States
|
| gptkbp:ATCCode |
N05BB01
|
| gptkbp:availableOn |
gptkb:sugar
capsule solution for injection |
| gptkbp:brand |
hydroxyzine
|
| gptkbp:chemicalClass |
first-generation antihistamine
|
| gptkbp:compatibleWith |
gptkb:United_Kingdom
|
| gptkbp:contraindication |
prolonged QT interval
early pregnancy |
| gptkbp:eliminationHalfLife |
20-25 hours
|
| gptkbp:excretion |
urine
|
| https://www.w3.org/2000/01/rdf-schema#label |
Vistaril
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Pfizer
|
| gptkbp:mechanismOfAction |
benzodiazepine
H1 receptor antagonist |
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:relatedTo |
gptkb:Atarax
|
| gptkbp:routeOfAdministration |
oral
intramuscular |
| gptkbp:sideEffect |
dizziness
headache drowsiness dry mouth |
| gptkbp:usedFor |
nausea
vomiting anxiety pruritus sedation allergic reactions |
| gptkbp:bfsParent |
gptkb:Hydroxyzine
|
| gptkbp:bfsLayer |
8
|